Sodium spirulan as a potent inhibitor of arterial smooth muscle cell proliferation in vitro

被引:66
作者
Kaji, T
Okabe, M
Shimada, S
Yamamoto, C
Fujiwara, Y
Lee, JB
Hayashi, T
机构
[1] Hokuriku Univ, Fac Pharmaceut Sci, Dept Environm Hlth, Kanazawa, Ishikawa 9201181, Japan
[2] Toyama Med & Pharmaceut Univ, Fac Pharmaceut Sci, Dept Pharmacognosy, Sugitani, Toyama 9300194, Japan
关键词
atherosclerosis; polysaccharide; smooth muscle cell; sodium spirulan; vascular;
D O I
10.1016/j.lfs.2003.09.061
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 [基础医学];
摘要
Sodium spirulan (Na-SP) is a sulfated polysaccharide with M-r similar to 220,000 isolated from the blue-green alga Spirulina platensis. The polysaccharide consists of two types of disaccharide repeating units, O-hexuronosylrhartmose (aldobiuronic acid) and O-rharrmosyl-3-O-methylrhamnose (acofriose) with sulfate groups, other minor saccharides and sodium ion. Since vascular smooth muscle cell proliferation is a crucial event in the progression of atherosclerosis, we investigated the effect of Na-SP on the proliferation of bovine arterial smooth muscle cells in culture. It was found that Na-SP markedly inhibits the proliferation without nonspecific cell damage. Either replacement of sodium ion with calcium ion or depolymerization of the Na-SP molecule to M-r similar to 14,700 maintained the inhibitory activity, however, removal of sodium ion or desulfation markedly reduced the activity. Heparin and heparan sulfate also inhibited vascular smooth muscle cell growth but their effect was weaker than that of Na-SP; dextran sulfate, chondroitin sulfate, dermatan sulfate and hyaluronan failed to inhibit the cell growth. The present data suggest that Na-SP is a potent inhibitor of arterial smooth muscle cell proliferation, and the inhibitory effect requires a certain minimum sequence of polysaccharide structure whose molecular conformation is maintained by sodium ion bound to sulfate group. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:2431 / 2439
页数:9
相关论文
共 34 条
[1]
Structure-activity relationships of heparin-mimicking compounds in induction of bFGF release from extracellular matrix and inhibition of smooth muscle cell proliferation and heparanase activity [J].
Benezra, M ;
Ishai-Michaeli, R ;
Ben-Sasson, SA ;
Vlodavsky, I .
JOURNAL OF CELLULAR PHYSIOLOGY, 2002, 192 (03) :276-285
[2]
HEPARIN INHIBITS PROLIFERATION OF FETAL VASCULAR SMOOTH-MUSCLE CELLS IN THE ABSENCE OF PLATELET-DERIVED GROWTH-FACTOR [J].
BENITZ, WE ;
LESSLER, DS ;
COULSON, JD ;
BERNFIELD, M .
JOURNAL OF CELLULAR PHYSIOLOGY, 1986, 127 (01) :1-7
[3]
Burke J M, 1979, Int Rev Connect Tissue Res, V8, P119
[4]
STRUCTURAL DETERMINANTS OF THE CAPACITY OF HEPARIN TO INHIBIT THE PROLIFERATION OF VASCULAR SMOOTH-MUSCLE CELLS [J].
CASTELLOT, JJ ;
BEELER, DL ;
ROSENBERG, RD ;
KARNOVSKY, MJ .
JOURNAL OF CELLULAR PHYSIOLOGY, 1984, 120 (03) :315-320
[5]
CASU B, 1989, ANN NY ACAD SCI, V556, P1
[6]
CHAN P, 1992, INT ANGIOL, V11, P261
[7]
CLOWES AW, 1987, INT ANGIOL, V6, P45
[8]
Ettenson DS, 2000, J CELL PHYSIOL, V184, P93, DOI 10.1002/(SICI)1097-4652(200007)184:1<93::AID-JCP10>3.0.CO
[9]
2-H
[10]
Effect of fully sulfated glycosaminoglycans on pulmonary artery smooth muscle cell proliferation [J].
Garg, HG ;
Joseph, PAM ;
Thompson, BT ;
Hales, CA ;
Toida, T ;
Imanari, T ;
Capila, I ;
Linhardt, RJ .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1999, 371 (02) :228-233